Le Lézard
Classified in: Health
Subject: PDT

WellDyneRx Announces Launch Of Outsourced Pharmacy Solutions


LAKELAND, Fla., Dec. 7, 2018 /PRNewswire/ -- WellDyneRx, a full-service, independent Pharmacy Benefit Manager (PBM), is pleased to announce the launch of their Outsourced Pharmacy Solutions, a suite of turnkey pharmacy services that enable healthcare organizations to offer comprehensive clinical solutions that optimize patient care. These services allow WellDyneRx's clients to leverage the company's clinical expertise, staff pharmacists, and negotiating experience to achieve optimal clinical outcomes while containing costs.

Outsourced Pharmacy Solutions

"Our Outsourced Pharmacy Solutions streamline operations for our clients while increasing profitable revenue streams," said Zach Johnson, President of WellDyneRx. "These services allow our clients to reduce their costs while taking advantage of our pharmacy resources.  We manage all of the day-to-day risks and responsibilities associated with maintaining pharmacy accreditations, hiring employees, managing drug inventories, and negotiating pricing with drug manufacturers."

WellDyneRx's Outsourced Pharmacy Solutions include Central Fill, Mail Order, and Specialty Pharmacy services:

"Our Outsourced Pharmacy Solutions allow our clients to offer comprehensive healthcare services that lower their delivery costs. It's one more way that WellDyneRx is committed to offering solutions that truly make a difference in the financial health of our clients and the care of their members," Johnson said.

To learn more about how WellDyneRx's Outsourced Pharmacy Solutions can help you streamline operations and increase revenue, visit www.WellDyneRx.com or call 855 OPS-WDRX (855.677.9379).

About WellDyneRx
WellDyneRx is a full-service Pharmacy Benefit Manager (PBM) that makes the little things matter for its clients, employees, partners, and members. WellDyneRx provides members with access to more than 66,000 retail pharmacies across the U.S. and mail order prescription services with the capacity to fulfill more than 15 million prescriptions per year. The company's offerings include a wholly-owned specialty pharmacy (www.USSpecialtyCare.com) that focuses on expensive specialized drugs; a national discount card program; and highly targeted pharmacy programs for Diabetes, Hepatitis C and Opioids to balance optimal clinical outcomes with minimized plan costs. Visit www.WellDyneRx.com to learn how you can optimize your health plan today.

WellDyneRx is a full-service, independent Pharmacy Benefit Manager (PBM) that makes the little things matter for our clients, employees, partners, and members. (PRNewsfoto/WellDyneRx)

SOURCE WellDyneRx


These press releases may also interest you

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare's novel SHP2 (Src Homology 2 domain containing...

at 19:30
Willow Biosciences Inc. ("Willow" or the "Company") , a leading biotechnology...

at 18:56
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:...

at 18:30
Striking Teamsters at pharmaceutical giant Cencora (formerly known as AmerisourceBergen) rallied today outside the company's Sacramento distribution center. The 124 warehouse workers are members of Teamsters Local 150 and have been on strike since...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....



News published on and distributed by: